Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 72 entries
Sorted by: Best Match Show Resources per page
Some defects of the Wechsler-Bellevue.

Journal of consulting psychology

GURVITZ MS.
PMID: 14927774
J Consult Psychol. 1952 Apr;16(2):124-6. doi: 10.1037/h0060977.

No abstract available.

Cite
GURVITZ MS. Some defects of the Wechsler-Bellevue. J Consult Psychol. 1952;16(2):124-6doi: 10.1037/h0060977.
GURVITZ, M. S. (1952). Some defects of the Wechsler-Bellevue. Journal of consulting psychology, 16(2), 124-6. https://doi.org/10.1037/h0060977
GURVITZ, M S. "Some defects of the Wechsler-Bellevue." Journal of consulting psychology vol. 16,2 (1952): 124-6. doi: https://doi.org/10.1037/h0060977
GURVITZ MS. Some defects of the Wechsler-Bellevue. J Consult Psychol. 1952 Apr;16(2):124-6. doi: 10.1037/h0060977. PMID: 14927774.
Copy Download .nbib Format: NLM
Construction of an Obligate Photoheterotrophic Mutant of the Cyanobacterium Synechocystis 6803 : Inactivation of the psbA Gene Family.

Plant physiology

Jansson C, Debus RJ, Osiewacz HD, Gurevitz M, McIntosh L.
PMID: 16665796
Plant Physiol. 1987 Dec;85(4):1021-5. doi: 10.1104/pp.85.4.1021.

psbA in Synechocystis 6803 was found to belong to a small multigene family with three copies. The psbA gene family was inactivated in vitro by insertation of bacterial drug resistance markers. Inactivation of all three genes resulted in a...

Cite
Jansson C, Debus RJ, Osiewacz HD, et al. Construction of an Obligate Photoheterotrophic Mutant of the Cyanobacterium Synechocystis 6803 : Inactivation of the psbA Gene Family. Plant Physiol. 1987;85(4):1021-5doi: 10.1104/pp.85.4.1021.
Jansson, C., Debus, R. J., Osiewacz, H. D., Gurevitz, M., & McIntosh, L. (1987). Construction of an Obligate Photoheterotrophic Mutant of the Cyanobacterium Synechocystis 6803 : Inactivation of the psbA Gene Family. Plant physiology, 85(4), 1021-5. https://doi.org/10.1104/pp.85.4.1021
Jansson, C, et al. "Construction of an Obligate Photoheterotrophic Mutant of the Cyanobacterium Synechocystis 6803 : Inactivation of the psbA Gene Family." Plant physiology vol. 85,4 (1987): 1021-5. doi: https://doi.org/10.1104/pp.85.4.1021
Jansson C, Debus RJ, Osiewacz HD, Gurevitz M, McIntosh L. Construction of an Obligate Photoheterotrophic Mutant of the Cyanobacterium Synechocystis 6803 : Inactivation of the psbA Gene Family. Plant Physiol. 1987 Dec;85(4):1021-5. doi: 10.1104/pp.85.4.1021. PMID: 16665796; PMCID: PMC1054386.
Copy Download .nbib Format: NLM
Do atypical antipsychotics cause weight gain in nursing home dementia residents?.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists

Gurevitz SL, Costakis T, Leiter J.
PMID: 16553497
Consult Pharm. 2004 Sep;19(9):809-12. doi: 10.4140/tcp.n.2004.809.

OBJECTIVE: To examine the effects of atypical antipsychotics on weight gain in the elderly resident with dementia or Alzheimer's disease, complicated with agitation and/or psychosis.DESIGN: Retrospective chart review.SETTING: Twenty-seven long-term care facilities in Indiana.PATIENTS/PARTICIPANTS: Residents of long-term care facilities...

Cite
Gurevitz SL, Costakis T, Leiter J. Do atypical antipsychotics cause weight gain in nursing home dementia residents?. Consult Pharm. 2004;19(9):809-12doi: 10.4140/tcp.n.2004.809.
Gurevitz, S. L., Costakis, T., & Leiter, J. (2004). Do atypical antipsychotics cause weight gain in nursing home dementia residents?. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 19(9), 809-12. https://doi.org/10.4140/tcp.n.2004.809
Gurevitz, Samuel L, et al. "Do atypical antipsychotics cause weight gain in nursing home dementia residents?." The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists vol. 19,9 (2004): 809-12. doi: https://doi.org/10.4140/tcp.n.2004.809
Gurevitz SL, Costakis T, Leiter J. Do atypical antipsychotics cause weight gain in nursing home dementia residents?. Consult Pharm. 2004 Sep;19(9):809-12. doi: 10.4140/tcp.n.2004.809. PMID: 16553497.
Copy Download .nbib Format: NLM
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells.

BMC medical genomics

Gurevich M, Tuller T, Rubinstein U, Or-Bach R, Achiron A.
PMID: 19624813
BMC Med Genomics. 2009 Jul 22;2:46. doi: 10.1186/1755-8794-2-46.

BACKGROUND: The ability to predict the spatial frequency of relapses in multiple sclerosis (MS) would enable physicians to decide when to intervene more aggressively and to plan clinical trials more accurately.METHODS: In the current study our objective was to...

Cite
Gurevich M, Tuller T, Rubinstein U, et al. Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med Genomics. 2009;2:46doi: 10.1186/1755-8794-2-46.
Gurevich, M., Tuller, T., Rubinstein, U., Or-Bach, R., & Achiron, A. (2009). Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC medical genomics, 246. https://doi.org/10.1186/1755-8794-2-46
Gurevich, Michael, et al. "Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells." BMC medical genomics vol. 2 (2009): 46. doi: https://doi.org/10.1186/1755-8794-2-46
Gurevich M, Tuller T, Rubinstein U, Or-Bach R, Achiron A. Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med Genomics. 2009 Jul 22;2:46. doi: 10.1186/1755-8794-2-46. PMID: 19624813; PMCID: PMC2725113.
Copy Download .nbib Format: NLM
Correction: The drug ornidazole inhibits photosynthesis in a different mechanism described for protozoa and anaerobic bacteria.

The Biochemical journal

Marcus Y, Tal N, Ronen M, Carmieli R, Gurevitz M.
PMID: 29242382
Biochem J. 2017 Dec 14;474(24):4269. doi: 10.1042/BCJ20160433_COR.

No abstract available.

Cite
Marcus Y, Tal N, Ronen M, et al. Correction: The drug ornidazole inhibits photosynthesis in a different mechanism described for protozoa and anaerobic bacteria. Biochem J. 2017;474(24):4269doi: 10.1042/BCJ20160433_COR.
Marcus, Y., Tal, N., Ronen, M., Carmieli, R., & Gurevitz, M. (2017). Correction: The drug ornidazole inhibits photosynthesis in a different mechanism described for protozoa and anaerobic bacteria. The Biochemical journal, 474(24), 4269. https://doi.org/10.1042/BCJ20160433_COR
Marcus, Yehouda, et al. "Correction: The drug ornidazole inhibits photosynthesis in a different mechanism described for protozoa and anaerobic bacteria." The Biochemical journal vol. 474,24 (2017): 4269. doi: https://doi.org/10.1042/BCJ20160433_COR
Marcus Y, Tal N, Ronen M, Carmieli R, Gurevitz M. Correction: The drug ornidazole inhibits photosynthesis in a different mechanism described for protozoa and anaerobic bacteria. Biochem J. 2017 Dec 14;474(24):4269. doi: 10.1042/BCJ20160433_COR. PMID: 29242382.
Copy Download .nbib Format: NLM
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A.
PMID: 34896265
Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08.

OBJECTIVES: Antiviral adaptive immunity involves memory B cells (MBC) and memory T cells (MTC). The dynamics of MBC and MTC in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescents warrant further investigation.METHODS: In this cross-sectional and longitudinal study, blood-derived...

Cite
Gurevich M, Zilkha-Falb R, Sonis P, et al. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021;115:208-214doi: 10.1016/j.ijid.2021.12.309.
Gurevich, M., Zilkha-Falb, R., Sonis, P., Magalashvili, D., Menascu, S., Flechter, S., Dolev, M., Mandel, M., & Achiron, A. (2021). SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 115208-214. https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich, Michael, et al. "SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 115 (2021): 208-214. doi: https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08. PMID: 34896265; PMCID: PMC8653411.
Copy Download .nbib Format: NLM
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A.
PMID: 34896265
Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08.

OBJECTIVES: Antiviral adaptive immunity involves memory B cells (MBC) and memory T cells (MTC). The dynamics of MBC and MTC in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescents warrant further investigation.METHODS: In this cross-sectional and longitudinal study, blood-derived...

Cite
Gurevich M, Zilkha-Falb R, Sonis P, et al. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021;115:208-214doi: 10.1016/j.ijid.2021.12.309.
Gurevich, M., Zilkha-Falb, R., Sonis, P., Magalashvili, D., Menascu, S., Flechter, S., Dolev, M., Mandel, M., & Achiron, A. (2021). SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 115208-214. https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich, Michael, et al. "SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 115 (2021): 208-214. doi: https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08. PMID: 34896265; PMCID: PMC8653411.
Copy Download .nbib Format: NLM
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A.
PMID: 34896265
Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08.

OBJECTIVES: Antiviral adaptive immunity involves memory B cells (MBC) and memory T cells (MTC). The dynamics of MBC and MTC in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescents warrant further investigation.METHODS: In this cross-sectional and longitudinal study, blood-derived...

Cite
Gurevich M, Zilkha-Falb R, Sonis P, et al. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021;115:208-214doi: 10.1016/j.ijid.2021.12.309.
Gurevich, M., Zilkha-Falb, R., Sonis, P., Magalashvili, D., Menascu, S., Flechter, S., Dolev, M., Mandel, M., & Achiron, A. (2021). SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 115208-214. https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich, Michael, et al. "SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 115 (2021): 208-214. doi: https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08. PMID: 34896265; PMCID: PMC8653411.
Copy Download .nbib Format: NLM
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A.
PMID: 34896265
Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08.

OBJECTIVES: Antiviral adaptive immunity involves memory B cells (MBC) and memory T cells (MTC). The dynamics of MBC and MTC in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescents warrant further investigation.METHODS: In this cross-sectional and longitudinal study, blood-derived...

Cite
Gurevich M, Zilkha-Falb R, Sonis P, et al. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021;115:208-214doi: 10.1016/j.ijid.2021.12.309.
Gurevich, M., Zilkha-Falb, R., Sonis, P., Magalashvili, D., Menascu, S., Flechter, S., Dolev, M., Mandel, M., & Achiron, A. (2021). SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 115208-214. https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich, Michael, et al. "SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 115 (2021): 208-214. doi: https://doi.org/10.1016/j.ijid.2021.12.309
Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Int J Infect Dis. 2021 Dec 08;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 08. PMID: 34896265; PMCID: PMC8653411.
Copy Download .nbib Format: NLM
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.

Therapeutic advances in neurological disorders

Achiron A, Mandel M, Dreyer-Alster S, Harari G, Magalashvili D, Sonis P, Dolev M, Menascu S, Flechter S, Falb R, Gurevich M.
PMID: 34035836
Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835. doi: 10.1177/17562864211012835. eCollection 2021.

BACKGROUND AND AIMS: The National Multiple Sclerosis Society and other expert organizations recommended that all patients with multiple sclerosis (MS) should be vaccinated against COVID-19. However, the effect of disease-modifying therapies (DMTs) on the efficacy to mount an appropriate...

Cite
Achiron A, Mandel M, Dreyer-Alster S, et al. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord. 2021;14:17562864211012835doi: 10.1177/17562864211012835.
Achiron, A., Mandel, M., Dreyer-Alster, S., Harari, G., Magalashvili, D., Sonis, P., Dolev, M., Menascu, S., Flechter, S., Falb, R., & Gurevich, M. (2021). Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Therapeutic advances in neurological disorders, 1417562864211012835. https://doi.org/10.1177/17562864211012835
Achiron, Anat, et al. "Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies." Therapeutic advances in neurological disorders vol. 14 (2021): 17562864211012835. doi: https://doi.org/10.1177/17562864211012835
Achiron A, Mandel M, Dreyer-Alster S, Harari G, Magalashvili D, Sonis P, Dolev M, Menascu S, Flechter S, Falb R, Gurevich M. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835. doi: 10.1177/17562864211012835. eCollection 2021. PMID: 34035836; PMCID: PMC8072850.
Copy Download .nbib Format: NLM
Collision Prevention for Duty-Cycle Receiver-Initiation MAC Protocol via Multiple Access Reservation (MAR-RiMAC).

Sensors (Basel, Switzerland)

Gurewitz O, Zaharia O.
PMID: 33379165
Sensors (Basel). 2020 Dec 28;21(1). doi: 10.3390/s21010127.

The prevalence of the Internet of Things (IoT) paradigm in more and more applications associated with our daily lives has induced a dense network in which numerous wireless devices, many of which have limited capabilities (e.g., power, memory, computation),...

Cite
Gurewitz O, Zaharia O. Collision Prevention for Duty-Cycle Receiver-Initiation MAC Protocol via Multiple Access Reservation (MAR-RiMAC). Sensors (Basel). 2020;21(1)doi: 10.3390/s21010127.
Gurewitz, O., & Zaharia, O. (2020). Collision Prevention for Duty-Cycle Receiver-Initiation MAC Protocol via Multiple Access Reservation (MAR-RiMAC). Sensors (Basel, Switzerland), 21(1), . https://doi.org/10.3390/s21010127
Gurewitz, Omer, and Zaharia, Oren. "Collision Prevention for Duty-Cycle Receiver-Initiation MAC Protocol via Multiple Access Reservation (MAR-RiMAC)." Sensors (Basel, Switzerland) vol. 21,1 (2020). doi: https://doi.org/10.3390/s21010127
Gurewitz O, Zaharia O. Collision Prevention for Duty-Cycle Receiver-Initiation MAC Protocol via Multiple Access Reservation (MAR-RiMAC). Sensors (Basel). 2020 Dec 28;21(1). doi: 10.3390/s21010127. PMID: 33379165; PMCID: PMC7796010.
Copy Download .nbib Format: NLM
Stereotactic radiosurgery for prostate cancer cerebral metastases: an international multicenter study.

Journal of neurosurgery

Pikis S, Bunevicius A, Lee CC, Yang HC, Zacharia BE, Liščák R, Simonova G, Tripathi M, Kumar N, Mathieu D, Perron R, Peker S, Samanci Y, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Lunsford LD, Mantziaris N, Sheehan JP.
PMID: 34598139
J Neurosurg. 2021 Oct 01;1-7. doi: 10.3171/2021.4.JNS21246. Epub 2021 Oct 01.

OBJECTIVE: As novel therapies improve survival for men with prostate cancer, intracranial metastatic disease has become more common. The purpose of this multicenter study was to evaluate the safety and efficacy of stereotactic radiosurgery (SRS) in the management of...

Cite
Pikis S, Bunevicius A, Lee CC, et al. Stereotactic radiosurgery for prostate cancer cerebral metastases: an international multicenter study. J Neurosurg. 2021;1-7doi: 10.3171/2021.4.JNS21246.
Pikis, S., Bunevicius, A., Lee, C. C., Yang, H. C., Zacharia, B. E., Liščák, R., Simonova, G., Tripathi, M., Kumar, N., Mathieu, D., Perron, R., Peker, S., Samanci, Y., Gurewitz, J., Bernstein, K., Kondziolka, D., Niranjan, A., Lunsford, L. D., Mantziaris, N., & Sheehan, J. P. (2021). Stereotactic radiosurgery for prostate cancer cerebral metastases: an international multicenter study. Journal of neurosurgery, 1-7. https://doi.org/10.3171/2021.4.JNS21246
Pikis, Stylianos, et al. "Stereotactic radiosurgery for prostate cancer cerebral metastases: an international multicenter study." Journal of neurosurgery vol. (2021): 1-7. doi: https://doi.org/10.3171/2021.4.JNS21246
Pikis S, Bunevicius A, Lee CC, Yang HC, Zacharia BE, Liščák R, Simonova G, Tripathi M, Kumar N, Mathieu D, Perron R, Peker S, Samanci Y, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Lunsford LD, Mantziaris N, Sheehan JP. Stereotactic radiosurgery for prostate cancer cerebral metastases: an international multicenter study. J Neurosurg. 2021 Oct 01;1-7. doi: 10.3171/2021.4.JNS21246. Epub 2021 Oct 01. PMID: 34598139.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 72 entries